The Cooper Companies, Inc. (NYSE:COO) Stock Holdings Lifted by First Horizon Advisors Inc.

First Horizon Advisors Inc. lifted its holdings in The Cooper Companies, Inc. (NYSE:COO) by 181.6% during the third quarter, HoldingsChannel reports. The institutional investor owned 276 shares of the medical device company’s stock after purchasing an additional 178 shares during the period. First Horizon Advisors Inc.’s holdings in Cooper Companies were worth $108,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of COO. American Century Companies Inc. lifted its position in shares of Cooper Companies by 28.4% in the 2nd quarter. American Century Companies Inc. now owns 1,490 shares of the medical device company’s stock worth $591,000 after buying an additional 330 shares during the last quarter. HighTower Advisors LLC increased its holdings in shares of Cooper Companies by 6.5% in the 2nd quarter. HighTower Advisors LLC now owns 3,925 shares of the medical device company’s stock worth $1,568,000 after acquiring an additional 239 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its holdings in shares of Cooper Companies by 3.8% in the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 9,079 shares of the medical device company’s stock worth $3,598,000 after acquiring an additional 330 shares during the period. Rafferty Asset Management LLC increased its holdings in shares of Cooper Companies by 16.4% in the 2nd quarter. Rafferty Asset Management LLC now owns 1,079 shares of the medical device company’s stock worth $428,000 after acquiring an additional 152 shares during the period. Finally, Citigroup Inc. increased its holdings in shares of Cooper Companies by 15.6% in the 2nd quarter. Citigroup Inc. now owns 59,325 shares of the medical device company’s stock worth $23,510,000 after acquiring an additional 7,989 shares during the period. Institutional investors own 96.44% of the company’s stock.

Cooper Companies stock opened at $410.52 on Friday. The stock has a market cap of $20.28 billion, a price-to-earnings ratio of 6.93, a PEG ratio of 2.70 and a beta of 0.88. The company has a current ratio of 2.00, a quick ratio of 1.20 and a debt-to-equity ratio of 0.20. The company’s 50-day moving average price is $406.35 and its two-hundred day moving average price is $416.65. The Cooper Companies, Inc. has a 52 week low of $359.84 and a 52 week high of $463.59.

Cooper Companies (NYSE:COO) last posted its quarterly earnings data on Thursday, December 2nd. The medical device company reported $3.28 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $3.37 by ($0.09). Cooper Companies had a net margin of 100.76% and a return on equity of 10.16%. The business had revenue of $759.10 million for the quarter, compared to the consensus estimate of $748.17 million. During the same quarter last year, the business posted $3.16 EPS. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. Research analysts expect that The Cooper Companies, Inc. will post 13.99 earnings per share for the current fiscal year.

The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, February 9th. Stockholders of record on Friday, January 21st will be given a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, January 20th. Cooper Companies’s dividend payout ratio (DPR) is 0.10%.

A number of analysts recently weighed in on the stock. Robert W. Baird reaffirmed a “hold” rating and issued a $431.00 price objective on shares of Cooper Companies in a report on Friday, December 3rd. Citigroup dropped their price objective on shares of Cooper Companies from $453.00 to $425.00 and set a “neutral” rating on the stock in a report on Friday, December 3rd. KeyCorp dropped their price objective on shares of Cooper Companies from $465.00 to $459.00 and set an “overweight” rating on the stock in a report on Friday, December 3rd. Finally, Guggenheim raised shares of Cooper Companies from a “neutral” rating to a “buy” rating and set a $495.00 price objective on the stock in a report on Monday, January 3rd. Two research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $451.50.

Cooper Companies Company Profile

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.

Featured Story: Day Trading

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.